Mereo BioPharma Group plc
MREO
$0.24
$0.00-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 500.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 500.00K | -- | -- |
| Cost of Revenue | 0.00 | -- | 132.00K | -- | -- |
| Gross Profit | 0.00 | -- | 368.00K | -- | -- |
| SG&A Expenses | 4.20M | 6.05M | 5.49M | 7.27M | 6.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.92M | 9.87M | 10.25M | 11.02M | 14.70M |
| Operating Income | -7.92M | -9.87M | -9.75M | -11.02M | -14.70M |
| Income Before Tax | -7.35M | -7.02M | -14.62M | -12.89M | -7.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.35M | -7.02M | -14.62M | -12.89M | -7.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.35M | -7.02M | -14.62M | -12.89M | -7.05M |
| EBIT | -7.92M | -9.87M | -9.75M | -11.02M | -14.70M |
| EBITDA | -7.46M | -9.82M | -9.59M | -10.87M | -14.55M |
| EPS Basic | -0.23 | -0.22 | -0.46 | -0.41 | -0.23 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.06 | -0.05 | -0.03 |
| EPS Diluted | -0.23 | -0.22 | -0.46 | -0.41 | -0.23 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.06 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 160.08M | 159.99M | 159.89M | 156.86M | 155.01M |
| Average Diluted Shares Outstanding | 32.02M | 32.00M | 31.98M | 31.37M | 31.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |